Načítá se...
CART序贯二次异基因造血干细胞移植治疗移植后复发急性B淋巴细胞白血病41例临床分析
OBJECTIVE: To study the clinical efficacy of chimeric antigen receptor T-cell（CART）treatment followed by a second allogeneic hematopoietic stem cell transplantation（allo-HSCT）in patients with B-cell acute lymphoblastic leukemia （ALL） who relapsed following the first HSCT. METHODS: Retrospective anal...
Uloženo v:
| Vydáno v: | Zhonghua Xue Ye Xue Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial office of Chinese Journal of Hematology
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120115/ https://ncbi.nlm.nih.gov/pubmed/33979977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.04.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|